Yomeishu Seizo Co., a Japanese medicinal liqueur manufacturer, is considering going private and has received acquisition proposals from several investment funds, according to people familiar with the matter.
The Tokyo-based company has appointed Mitsubishi UFJ Morgan Stanley Securities Co. as its financial adviser to explore capital strategies, including delisting, said the people, who asked not to be identified as the information isn’t public. Yomeishu has reached out to potential buyers and investment funds for a possible sale and has recently conducted a first-round bidding process, according to the people.
AloJapan.com